7eed8872bd8560ff38ef85e04784706d44d74366e58341fecd00174cff3d9d




28b9d932da836eff3dec82e24789716b0b701aa3479698f7c2356c1561c34d317b78

1.ํ—ค์ง€ํŽ€๋“œ-7๋Œ€๊ธฐ์ˆ ์ฃผ ๋…ธ์ถœ์ด ์‚ฌ์ƒ์ตœ๋Œ€์น˜

28b9d932da836eff3ded80e646877d6f9c56dc4541b629ae15c8040b50e30f1afd19


2.ํœ˜๋ฐœ์œ ์˜ย  ๊ฐ€ํŒŒ๋ฅธ์ƒ์Šน

์›”์ŠคํŠธ๋ฆฌํŠธ์ €๋„(WSJ)์€ 28์ผ(ํ˜„์ง€์‹œ๊ฐ„) ์˜ฌํ•ด ๋“ค์–ด ์ƒ์Šน์„ธ๋กœ ์ „ํ™˜ํ•œ ํœ˜๋ฐœ์œ  ๊ฐ€๊ฒฉ์ด ๋ฏธ๊ตญ์˜ ์ธํ”Œ๋ ˆ์ด์…˜ ์••๋ ฅ์„ ๋†’์ด๊ณ  ์žˆ๋‹ค๊ณ  ๋ณด๋„ํ–ˆ๋‹ค.





3.๋ฏธ๊ตญ์ž๋™์ฐจ ํŒ๋งค-ย  ๊ฒฝ์ œ์œ„๊ธฐ๋กœ ๋‘”ํ™”

7ceb8975b78a6cfe3aea81e1469f34334d74fb7a85e4d7e3b63105f26c

4.๋ฐ”์ด๋“ ํ–‰์ •๋ถ€- ๋ฉ”๋””์ผ€์–ด 10๊ฐœ ๊ฐ€๊ฒฉ ํ˜‘์ƒ

7ceb8975b68368f63fe780e5429f3433f73836d08e23672789a6c5a8d9

๋Œ€์ƒ:

Bristol ์‚ฌ์˜ Eliquis

Boehringer Ingelheim์‚ฌ์˜ Jardiance

Johnson & Johnson ์‚ฌ์˜ Xarelto

MercK ์‚ฌ์˜ Januvia

AstraZeneca ์‚ฌ์˜ Farxiga

Novartis์‚ฌ์˜ Entresto

Amgen์‚ฌ์˜ Enbrel

AbbVie์‚ฌ์˜ Imbruvica

Janssen ์‚ฌ์˜ Stelara

+NOVO Nordisk ์‚ฌ์˜ Fisap






์—ฐ์„ค







22adc42fe8db22a320b5c6b0119c75738aba6c70f548d0f6d4df3a0b059f

7ceb8975b6836af33fed84e34e9f343301b267934259fd309db5c473

๋ผ์ด๋ชฌ๋„,๋ฏธ๊ตญ ์ƒ๋ฌด๋ถ€ ์žฅ๊ด€

๋ฏธ์ค‘ ํ†ต์‹  ๋ผ์ธ์„ ์—ด ์ˆ˜ ์žˆ์—ˆ์Šต๋‹ˆ๋‹ค. ์šฐ๋ฆฌ๋Š” ์ค‘๊ตญ์˜ ์กฐ์น˜๊ฐ€ ์žˆ๋Š”์ง€ ๊ธฐ๋‹ค๋ฆด ๊ฒƒ์ž…๋‹ˆ๋‹ค.

๋ฏธ๊ตญ์ด ์ค‘๊ตญ ๊ด€๋ฆฌ๋“ค๊ณผ์˜ ํšŒ๋‹ด์—์„œ "์šฐ๋ฆฌ์˜ ๊ธฐ์ˆ  ์ œํ•œ์€ ํ˜‘์ƒํ•  ์ˆ˜ ์—†๋‹ค"๋Š” ๋ฉ”์‹œ์ง€๋ฅผ ์ „๋‹ฌํ–ˆ๋‹ค๊ณ  ๋ฐํ˜”์Šต๋‹ˆ๋‹ค.

์šฐ๋ฆฌ๋Š” ์ค‘๊ตญ์˜ ์™• ๋ถ€์žฅ๊ณผ ํ•„์š”์— ๋”ฐ๋ผ ์ž์ฃผ ๋Œ€ํ™”ํ•˜๊ธฐ๋กœ ํ•ฉ์˜ํ–ˆ์Šต๋‹ˆ๋‹ค.











์œ ๋Ÿฝ/๊ธฐํƒ€ ๊ตญ๊ฐ€



28b9d932da836eff3dec82e24480736528e68e9e97c2a98e45e385865ab6745ece30





1.์ดํƒˆ๋ฆฌ์•„ -์—ฌ๋ฆ„์˜ํญ์„ค



2.์ดํƒˆ๋ฆฌ์•„์˜ ์ „๊ธฐ ์š”๊ธˆ์€ ์ง€๋‚œ์ฃผ 29.9% ์ƒ์Šนํ–ˆ์Šต๋‹ˆ๋‹ค.


28b9d932da836eff3ded80ec4589746aade0ac9e0fb5ae6ea78ea3612ba46c57e5d2


3.์—˜๋‹ˆ๋‡จ์˜ ํญํ’์šฐ ๊ตฌ๋ฆ„์ด ์ „ ์„ธ๊ณ„ ์‹๋Ÿ‰ ๊ฐ€๊ฒฉ์„ ๋ฎ์นฉ๋‹ˆ๋‹ค.


28b9d932da836eff3ded8ee745857d6c06a36c42c6ede5fa0ccdef8b34ba7db7d345


4.๋…์ผ ์—ฐํ•ฉ, ๋ฒ•์ธ์„ธ ๊ฐ๋ฉด์„ ์œ„ํ•œ 65์–ต ์œ ๋กœ ํ•ฉ์˜

7ceb8975b78a6cf036ea8fe6429f3433a50821af676f8ff31235eb4670

5.์‚ฌ์šฐ๋””-์™ธํ™˜๋ณด์œ ๊ณ  ๊ธ‰๊ฒฉํ•˜๊ฒŒ๊ฐ์†Œ

28b9d932da836eff3ded8fe74f81706fd75cdae8377f29e71bfa2e07808a6304f6dc

์‚ฌ์šฐ๋”” ์•„๋ผ๋น„์•„์˜ ์™ธํ™˜ ๋ณด์œ ๊ณ ๋Š” ์ง€๋‚œ๋‹ฌ 160 ์–ต ๋‹ฌ๋Ÿฌ ์ด์ƒ ๊ฐ์†Œํ•˜์—ฌ ์œ ๊ฐ€๊ฐ€ ๋Œ€์œ ํ–‰์ด ์‹ฌํ•ด์ง€๋ฉด์„œ ๋งˆ์ด๋„ˆ์Šค๋กœ ์ „ํ™˜ ํ•œ ์ดํ›„ ๊ฐ€์žฅ ๊ธ‰๊ฒฉํžˆ ๊ฐ์†Œํ–ˆ์Šต๋‹ˆ๋‹ค.
















์•„์‹œ์•„






28b9d932da836eff3dec82e24485716ffd35614c5e5e94778090c8a3ca704a3d3187

1.ํ•œ๊ตญ ์—ฐ๊ธฐ๊ธˆ-5๊ฐœ์›”์งธํŒ”์ž




2.์†Œ๋“ ๋ณด๋‹ค ๋งŽ์€ '๊ฐ€๊ณ„ ๋นš'โ€ฆ์„œ์šธ, 1์ธ๋‹น 1์–ต์› ๋„˜์—ˆ๋‹ค

3.ํ•œ๊ตญ-์„ธ๊ณ„์ตœ์ดˆ์‚ผ๊ฐ๊ฒฉ์ž๋ฌผ์งˆ๋กœ ์–‘์ž๋ฐœ๊ฒฌ



4. ํ•œ๊ตญ, 20๋…„ ๋งŒ์— ๊ฐ€์žฅ ์ ์€ ์˜ˆ์‚ฐ ์ฆ๊ฐ€

7ceb8975b7856efe3aef8fe3419f34335ca6fc3dd96cd36be76fe4508a

ํ•œ๊ตญ, 20๋…„ ๋งŒ์— ๊ฐ€์žฅ ์ ์€ ์˜ˆ์‚ฐ ์ฆ๊ฐ€๋กœ ์žฌ์ • ๊ธฐ๊ฐ• ํ™•๋ฆฝ์— ์ง‘์ค‘



์–ด๋‹ย 





28b9d932da836eff3dec86e244867d65fc6ff4b404c62a065365fe79bfe2a825fb08

28b9d932da836eff3dec86e244897268ed8562e36a64b6ac609e122d9a34fb1507





28b9d932da836eff3dec82e245837d6429af250ac7413352098013e48a0a2466dc06

28b9d932da836eff3dec82e24582726874568c482de92fc3c0687361b8338b6f7a




์ง€ํ‘œ


1.์ผ๋ณธ์‹ค์—…๋ฅ 

28b9d932da836eff3ded80e04e887d698c4fc02484d3a5d65e68354c7018e3db02


2.๋ฒ ํŠธ๋‚จ CPI


28b9d932da836eff3ded8ee44580746f9f273bb4f1f57c61f341ea79b38dfda94c45

3.๋…์ผ ์†Œ๋น„์ž ๋™ํ–ฅ

28b9d932da836eff3ded8eec42817c6d336612d9ea3034f76323e6422571066775

4.๋ ˆ๋“œ๋ถ์ง€์ˆ˜

28b9d932da836eff3dec87e64e8275641b140efac171096aff344a2470e548f93c2a

6.์ฃผํƒ ๊ฐ€๊ฒฉ์ง€์ˆ˜

28b9d932da836eff3dec87e1478677685affef109e2d982a75d9e0840ab29ceffac2

7.์กธํŠธ์ง€์ˆ˜

28b9d932da836eff3dec87e24e83706afe6e51467c07c8edcb7040d8a91b8928f3

8.๋ธ๋Ÿฌ์Šค์—ฐ์ค€์„œ๋น„์Šค

28b9d932da836eff3dec87ec4289746988ca5f8059900effc2d67811d1e94f2a19
























์‹œ์žฅ ์ƒํ™ฉ


1.์‹œ์žฅ

28b9d932da836eff3dec82e24383746f528bbfb1d347e2ef408ae49c98f0996ff700

28b9d932da836eff3dec82e24383726b93ab26eb2a25f6127f0b0d3b5bc1be64d5b1

28b9d932da836eff3dec82e243827668f9947da22ae87a3caa9dfdf5c632a78ac0ce


2.ํ‚ค์›€๊ฑธ์ฆˆ



28b9d932da836eff3dec82e243877664c338aa7674f27168c8d3b8176ce583f9e566

28b9d932da836eff3dec82e243867468872c14285e810f8a26042f573f82ef492e2f

42

- dc official App